Movement Alert|Veracyte Intraday Rise 5.67%, shares rebound after post-earnings selloff and analyst target cuts

Market Focus
11/19

On November 19, Veracyte rose 5.67% in Regular Trading, trading at $25.54/share, with turnover of $14.98 million.

The latest publicly available catalyst is a rebound following the company’s recent post-earnings volatility: Veracyte previously reported third-quarter adjusted EPS of $0.51 and revenue of $151.8 million, both above consensus, but narrowed full-year revenue guidance to $590 million-$593 million from $590 million-$596 million, which had triggered a sharp selloff.

Subsequently, several brokers cut their price targets to $35, including Leerink, UBS and Guggenheim, while maintaining a more cautious stance on the shares. The current rise appears to reflect stabilization after that reset in expectations rather than a new fundamental announcement on the day.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10